AI trial optimization Phesi offers AI-powered trial design optimization, real-world data from extensive patient pools, and tools like Digital Patient Profiles and Patient Access Score. Sales opportunities include positioning to sponsors seeking faster trial cycles, improved enrollment forecasting, and smarter site selection across global networks.

Global data breadth With data from over 300 million patients across 223 countries and 4,000 indications, Phesi can address multinational programs and diverse therapeutic areas. Revenue opportunities exist in multinational sponsor collaborations, investigator site profiling, and enabling external control arms for global trials.

Expansion into sites Recent launches such as the self-service Investigator Site Profile solution indicate a focus on site-level optimization and pruning underperforming sites. This creates upsell opportunities for sponsors to streamline site engagement, improve enrollment efficiency, and reduce non-productive site activity.

Recognition and credibility Industry awards for AI-enabled trial design and technology leadership bolster Phesi’s credibility with prospective clients. Use these accolades in sales conversations to penetrate larger life sciences organizations seeking innovative, award-winning analytics partners.

Product-led innovations New offerings like Patient Burden Score and Digital Twins position Phesi at the intersection of patient experience and trial efficiency. Opportunities lie in selling end-to-end improvements for patient retention, protocol design, and external control arm feasibility across trials.